Gastric Ulcer
📧 Sign up to get email alerts when something new happens for Gastric Ulcer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-09-21FDA Approved: LANSOPRAZOLE — Original Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's original ANDA for lansoprazole, enabling a generic version to be marketed for acid-related disorders.
-
FDA approval · 2017-08-30FDA Approved: LANSOPRAZOLE — Original Application (Lifestar Pharma LLC.)
FDA approves a generic lansoprazole under an Original Application (ANDA) for Lifestar Pharma LLC.
-
FDA approval · 2017-08-18FDA Approved: KIRKLAND SIGNATURE ESOMEPRAZOLE MAGNESIUM — Original Application (Costco Wholesale Company)
The FDA approved the original generic application for Kirkland Signature Esomeprazole Magnesium, a generic version of esomeprazole magnesium…
-
FDA approval · 2017-08-15FDA Approved: CARAFATE — Supplemental Application (Allergan, Inc.)
The FDA approved Allergan's supplemental application for CARAFATE (sucralfate). This approval updates the product's labeling and/or indicati…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed Conditions [Phase 1]
This Phase 1 trial compared the bioavailability of two test products of a fixed-dose combination capsule containing aspirin 100 mg and panto…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting Conditions [Phase 1]
Phase 1 bioavailability study comparing two test products of a fixed-dose capsule containing acetylsalicylic acid 100 mg and pantoprazole 20…
-
FDA approval · 2017-07-06FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Protonix Delayed-Release (pantoprazole sodium) from Wyeth/Pfizer to update the drug's labeling.
-
FDA approval · 2017-07-05FDA Approved: BERKLEY AND JENSEN OMEPRAZOLE — Original Application (BJWC)
FDA approved Berkley and Jensen Omeprazole under an original application; the product is a proton pump inhibitor indicated for gastroesophag…
-
FDA approval · 2017-07-03FDA Approved: OMEPRAZOLE — Original Application (Golden State Medical Supply, Inc.)
FDA approves a generic omeprazole from Golden State Medical Supply, Inc. under an Original Application (ANDA 203481).
-
FDA approval · 2017-06-30FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Civica, Inc.)
The FDA approved Civica, Inc.'s pantoprazole sodium original application (NDA 209463), a proton pump inhibitor for acid-related conditions a…
-
FDA approval · 2017-06-26FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (XLCare Pharmaceuticals Inc.)
FDA approved a supplemental application for pantoprazole sodium by XLCare Pharmaceuticals Inc., validating continued approval of their panto…
-
FDA approval · 2017-05-09FDA Approved: EQUATE LANSOPRAZOLE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for Equate Lansoprazole (lansoprazole) from Wal-Mart Stores Inc, related to this generic product.
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: Effect of Selective COX-2 Inhibition on Ulcer Healing [Phase 3]
Phase 3 trial investigating the effect of selective COX-2 inhibition on ulcer healing has completed, in patients with arthritis and gastric …
-
FDA approval · 2017-02-17FDA Approved: RABEPRAZOLE SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved an original ANDA for a generic rabeprazole sodium product from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet [Phase 1]
This clinical trial update reports a Phase 1 pharmacokinetics comparison of lafutidine and irsogladine maleate tablets. The study in gastric…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases [Phase 3]
Phase III results for D961H at 10 mg and 20 mg in Japanese pediatric patients with gastrointestinal acid-related diseases have been complete…
-
FDA approval · 2016-12-06FDA Approved: OMEPRAZOLE SODIUM BICARBONATE — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s original application for Omeprazole Sodium Bicarbonate (generic). This is a generic omeprazole-sodium bicarbon…
-
FDA approval · 2016-12-01FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) from AmerisourceBergen, updating labeling and…
-
FDA approval · 2016-10-24FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Prilosec (omeprazole magnesium) submitted by Covis Pharma US, Inc.
-
FDA approval · 2016-10-24FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2016-10-24FDA Approved: ESOMEPRAZOLE STRONTIUM — Supplemental Application (R2 Pharma, LLC)
The FDA approved a supplemental application to authorize the marketing of esomeprazole strontium, a salt form of esomeprazole, for use in th…
-
FDA approval · 2016-10-14FDA Approved: LANSOPRAZOLE — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s generic lansoprazole under an original ANDA.
-
FDA approval · 2016-08-01FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for PEPCID AC MAXIMUM STRENGTH (famotidine) by Kenvue Brands LLC, updating the product labeling as p…
-
FDA approval · 2016-07-25FDA Approved: LANSOPRAZOLE — Original Application (Xiromed LLC)
FDA approved the original application for a generic lansoprazole from Xiromed LLC.
-
FDA approval · 2016-07-15FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Original Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s original-application generic combination of omeprazole and sodium bicarbonate for acid-related disorde…